• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:不明原因的轻度低磷血症和血清成纤维细胞生长因子23(FGF23)浓度极高

Case Report: Unexplained Mild Hypophosphatemia and Very High Serum FGF23 Concentrations.

作者信息

Bosman Ariadne, Ratsma Danielle Ma, van der Eerden Bram Cj, Zillikens M Carola

机构信息

Department of Internal Medicine Erasmus MC, University Medical Center Rotterdam The Netherlands.

出版信息

JBMR Plus. 2023 Aug 9;7(10):e10790. doi: 10.1002/jbm4.10790. eCollection 2023 Oct.

DOI:10.1002/jbm4.10790
PMID:37808399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10556273/
Abstract

Fibroblast growth factor (FGF)23 is one of the major regulators of phosphate homeostasis. Hypophosphatemia can lead to muscle weakness, fatigue, and osteomalacia. In the setting of hypophosphatemia, serum FGF23 can be measured to differentiate between FGF23-mediated and non-FGF23-mediated renal phosphate wasting. C-terminal FGF23 (cFGF23) assays detect both cFGF23 and intact FGF23 (iFGF23). Circulating FGF23 is regulated by 1.25-dihydroxy-vitamin D, parathyroid hormone (PTH), serum phosphate, and serum calcium but also by, for example, iron status, inflammation, erythropoietin, and hypoxia-inducible-factor-1-α. We present the case of a 48-year-old woman with unexplained mild hypophosphatemia, very high cFGF23, and normal iFGF23. The patient proved to have an iron deficiency. Iron deficiency alters the iFGF23-to-cFGF23 ratio. After initiation of iron treatment, cFGF23 strongly decreased. This case report illustrates the limitation of cFGF23 assays and urges clinicians to be aware that cFGF23 concentrations do not necessarily reflect iFGF23 concentrations and that alternative causes for its elevation should be considered (eg, iron deficiency). © 2023 The Authors. published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.

摘要

成纤维细胞生长因子(FGF)23是磷稳态的主要调节因子之一。低磷血症可导致肌肉无力、疲劳和骨软化症。在低磷血症的情况下,可测量血清FGF23以区分FGF23介导的和非FGF23介导的肾性磷消耗。C末端FGF23(cFGF23)检测可同时检测cFGF23和完整FGF23(iFGF23)。循环中的FGF23受1,25 - 二羟维生素D、甲状旁腺激素(PTH)、血清磷和血清钙的调节,但也受例如铁状态、炎症、促红细胞生成素和缺氧诱导因子-1-α的调节。我们报告了一例48岁女性病例,其存在不明原因的轻度低磷血症、cFGF23水平极高而iFGF23水平正常。该患者被证实存在缺铁。缺铁会改变iFGF23与cFGF23的比例。开始铁剂治疗后,cFGF23大幅下降。本病例报告说明了cFGF23检测的局限性,并敦促临床医生意识到cFGF23浓度不一定反映iFGF23浓度,且应考虑其升高的其他原因(如缺铁)。© 2023作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba2/10556273/ec3e5b25200f/JBM4-7-e10790-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba2/10556273/ec3e5b25200f/JBM4-7-e10790-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba2/10556273/ec3e5b25200f/JBM4-7-e10790-g002.jpg

相似文献

1
Case Report: Unexplained Mild Hypophosphatemia and Very High Serum FGF23 Concentrations.病例报告:不明原因的轻度低磷血症和血清成纤维细胞生长因子23(FGF23)浓度极高
JBMR Plus. 2023 Aug 9;7(10):e10790. doi: 10.1002/jbm4.10790. eCollection 2023 Oct.
2
Renal Phosphate Handling: Independent Effects of Circulating FGF23, PTH, and Calcium.肾脏对磷酸盐的处理:循环中的成纤维细胞生长因子23(FGF23)、甲状旁腺激素(PTH)和钙的独立作用。
JBMR Plus. 2020 Dec 9;5(2):e10437. doi: 10.1002/jbm4.10437. eCollection 2021 Feb.
3
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.缺铁性贫血及其治疗对女性成纤维细胞生长因子 23 和磷稳态的影响。
J Bone Miner Res. 2013 Aug;28(8):1793-803. doi: 10.1002/jbmr.1923.
4
Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia.测定 FGF23 水平以诊断 FGF23 介导的低磷血症。
J Bone Miner Res. 2022 Nov;37(11):2174-2185. doi: 10.1002/jbmr.4702. Epub 2022 Oct 17.
5
Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.羧基麦芽糖铁对矿物质和骨代谢标志物的影响:一项针对缺铁女性的单中心前瞻性观察研究。
Bone. 2020 Dec;141:115559. doi: 10.1016/j.bone.2020.115559. Epub 2020 Jul 28.
6
Renal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans.人内源性成纤维细胞生长因子 23(FGF23)及其片段的肾清除率
J Bone Miner Res. 2022 Jun;37(6):1170-1178. doi: 10.1002/jbmr.4553. Epub 2022 Apr 25.
7
Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation.老年人早期肾功能损害时肾-骨轴调节因子、炎症和铁状态的改变及维生素 D 补充的影响。
Age Ageing. 2024 May 1;53(5). doi: 10.1093/ageing/afae096.
8
Associations Between Intravenous Iron, Inflammation and FGF23 in Non-Dialysis Patients with Chronic Kidney Disease Stages 3-5.非透析慢性肾脏病3-5期患者静脉补铁、炎症与成纤维细胞生长因子23之间的关联
Kidney Blood Press Res. 2018;43(1):143-151. doi: 10.1159/000487368. Epub 2018 Feb 8.
9
Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.慢性肾脏病合并心力衰竭患者红细胞分布宽度与成纤维细胞生长因子23裂解的关系
PLoS One. 2015 Jun 16;10(6):e0128994. doi: 10.1371/journal.pone.0128994. eCollection 2015.
10
Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism.原发性甲状旁腺功能亢进症手术患者围手术期FGF23的变化
Endocr Connect. 2022 Jan 31;11(1):e210430. doi: 10.1530/EC-21-0430.

本文引用的文献

1
Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia.测定 FGF23 水平以诊断 FGF23 介导的低磷血症。
J Bone Miner Res. 2022 Nov;37(11):2174-2185. doi: 10.1002/jbmr.4702. Epub 2022 Oct 17.
2
Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases.肿瘤相关性骨软化症:895 例的系统临床综述。
Calcif Tissue Int. 2022 Oct;111(4):367-379. doi: 10.1007/s00223-022-01005-8. Epub 2022 Jul 20.
3
Cortisol and Phosphate Homeostasis: Cushing's Syndrome Is Associated With Reversible Hypophosphatemia.
皮质醇和磷酸盐稳态:库欣综合征与可逆性低磷血症有关。
Front Endocrinol (Lausanne). 2021 Sep 30;12:733793. doi: 10.3389/fendo.2021.733793. eCollection 2021.
4
Serum Phosphate, BMI, and Body Composition of Middle-Aged and Older Adults: A Cross-Sectional Association Analysis and Bidirectional Mendelian Randomization Study.血清磷酸盐、BMI 和中老年人体成分:一项横断面关联分析和双向孟德尔随机化研究。
J Nutr. 2022 Jan 11;152(1):276-285. doi: 10.1093/jn/nxab351.
5
Upstream Regulators of Fibroblast Growth Factor 23.成纤维细胞生长因子 23 的上游调节物。
Front Endocrinol (Lausanne). 2021 Feb 26;12:588096. doi: 10.3389/fendo.2021.588096. eCollection 2021.
6
Approach to patients with hypophosphataemia.低磷血症患者的处理方法。
Lancet Diabetes Endocrinol. 2020 Feb;8(2):163-174. doi: 10.1016/S2213-8587(19)30426-7. Epub 2020 Jan 7.
7
Worsening of unrecognized tumour-induced osteomalacia with inadvertent use of recombinant human parathyroid hormone.未识别的肿瘤诱导性骨软化症恶化,意外使用重组人甲状旁腺激素。
Endokrynol Pol. 2020;71(1):102-103. doi: 10.5603/EP.a2019.0045. Epub 2019 Sep 30.
8
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.成纤维细胞生长因子 23 在磷酸盐、铁代谢和红细胞生成的十字路口。
Nat Rev Nephrol. 2020 Jan;16(1):7-19. doi: 10.1038/s41581-019-0189-5. Epub 2019 Sep 13.
9
Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF.铁、促红细胞生成素和低氧诱导因子对成纤维细胞生长因子23的调节
Curr Mol Biol Rep. 2019 Mar;5(1):8-17. doi: 10.1007/s40610-019-0110-9. Epub 2019 Jan 25.
10
The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research.红细胞祖细胞中的促红细胞生成素-成纤维细胞生长因子23信号通路:开启一个新的研究领域。
Front Physiol. 2019 Mar 26;10:304. doi: 10.3389/fphys.2019.00304. eCollection 2019.